Table 1.

Diabetes Care Indicators and Mean Values

Diabetes Care Indicator	Average across All Facilities	Range of Mean Values across Facilities (N=13)†
Process Measures*
Hemoglobin A1c (HbA1c) obtained (%)	83	68–91
Low density lipoprotein cholesterol (LDL-C) successfully measured (%)	38‡	33–56
Lipid profile obtained (%)	57‡	41–84
Intermediate Outcomes
Last HbA1c value (mean [SD])	7.8% [1.9]	7.1%–8.8%
Last HbA1c value ≥9.5% (%)	15	5–32
Last LDL-C value (mean [SD])	3.2 mmol/L [.85]	2.9–3.5 mmol/L
	124 mg/dL [33]	112–134 mg/dL
Last LDL-C value ≥3.6 mmol/L (140 mg/dL) (%)	27	18–34
Last LDL-C value <3.6 mmol/L (140 mg/dL) or on a statin (%)	85	79–91
Resource Use#
Cost of hypoglycemic medications (mean [SD])	$138 [189]	$106–$170
Cost of home glucose monitoring for patients not on insulin (mean [SD])	$66 [93]	$6–$122
Cost of home glucose monitoring for patients on insulin (mean [SD])	$152 [162]	$78–$224
Cost of calcium channel blockers (mean [SD])	$75 [136]	$46–$96

^*Percent of patients with test obtained in past 12 months.

^†LDL related measures are based on nine facilities due to incomplete lab data from four facilities, while HbA1c measures and the lipid profile measure are based on 12 facilities due to incomplete reporting from one facility.

LDL-C values are converted to conventional units by dividing mmol/L by .0259.

^‡An LDL-C value could not be calculated for approximately one-third of those who had a lipid profile obtained due to elevated triglyceride values.

^#Average annual cost per patient.